New Trust Director of R&D named
20/04/2022
This article is more than two years old.
Oxford University Hospitals (OUH) has announced the appointment of Professor Adrian Banning as its new Director of Research and Development.
A Consultant Cardiologist, Prof Banning takes over from Professor Keith Channon, who was recently appointed Head of Department in the University of Oxford’s Radcliffe Department of Medicine.
Prof Banning came to Oxford in 1995, became a consultant in 1999 and was appointed as a full Professor of Interventional Cardiology by Oxford University in 2011.
“I have a passion for research and remain a firm believer in the role of research in improving the care we give to our patients,” Prof Banning said.
“I’d like to thank Keith for his exceptional leadership of research and development in OUH over the past decade, during which there have been numerous important discoveries that have benefited NHS patients. I’m proud to be playing a key role in ensuring that continues.
“I will also be continuing Keith’s championing of Oxford’s healthcare research ecosystem, epitomised by the Oxford Academic Health Partners, which harnesses the collective expertise and capabilities of OUH, the University of Oxford, Oxford Health NHS Foundation Trust and Oxford Brookes University. I will build on recent positive developments, such as the expansion of the Oxford Joint Research Office and the major investment in developing nursing, midwifery and allied health professionals’ research leadership and infrastructure,” Prof Banning said.
Prof Banning has been Lead Clinician for the Thames Valley Cardiac Clinical Network, Lead Clinician for South Central Cardiac Cardiovascular Research, Clinical Director and Divisional Director at OUH, and a Co-theme Lead for the Oxford Biomedical Research Centre’s Cardiac theme.
He has published over 450 research papers and has extensive experience in research delivery and teaching. He has organised many medical conferences, including the Cardiac Intervention Society’s inaugural annual conference for Allied Health Professionals. He has sat on a number of committees responsible for developing national and international clinical guidelines and continues to chair a number of committees nationally.
OUH Chief Medical Office Prof Meghana Pandit said: “I’d like to welcome Adrian to what is a key role not just for research in our Trust but for the Oxford healthcare research partnership. With his distinguished clinical and research track record, I’m sure he will be the right person to build on the great work Keith has done to keep Oxford as a world-leading centre for medical research.”